secwatch.observer — SEC 8-K summary
======================================

Issuer:     RADNOSTIX INC (INIS)
CIK:        0001038277
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001437749-25-031241
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

International Isotopes CEO Bagerdjian signs 5-year employment agreement; Dr. Fu appointed to board
--------------------------------------------------------------------------------

- CEO Shahe Bagerdjian's base salary set at $314K with automatic 5% annual increases through 2030 and up to $250K in milestone raises based on quarterly revenue hitting $3.75M–$25M.
- Bagerdjian awarded 37.5M RSUs vesting in tranches at share prices of $0.10 to $0.30 over 60 consecutive calendar days; immediate vesting upon termination without cause or change of control.
- Dr. Duke W. Fu, nuclear pharmacist executive, appointed to board and audit committee; receives 250K RSUs annually.
- Bylaws amended: clarify special meeting business, add advance notice for shareholder proposals and director nominations, allow advisory directors, and update indemnification/insurance provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1038277/000143774925031241/0001437749-25-031241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1038277/000143774925031241/inis20251016_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer